top of page
AD7P1674.JPG

Our portfolio

We help inventions grow!

We focus on the transfer of new technologies into practice. We were established by the Institute of Organic Chemistry and Biochemistry of the CAS and are dedicated to innovations in the field of drug development, diagnostics and medical devices originating from academic institutions. We support the creation of spin-off companies and the sale of licenses. So far, we have participated in the creation or otherwise supported 15 spin-off companies from 5 countries, have an equity stake in 9 of them and have invested over 70 million crowns. Overall, the spin-offs in i&i Prague's portfolio have raised more than CZK 1.8 billion from other investors.

logo DMCH barva vyska ctverec_edited
sophomer_ctverec
lamx_edited
peptherapy_edited
periotrap_edited
sulfotools_edited
sampling human_mensi4
dracen_edited
casinvent_edited

Our portfolio

casinvent_edited.jpg

CasInvent Pharma

Casein Kinase 1 inhibitors for cancer treatment

peptherapy_edited.jpg

PEP-Therapy

Innovative peptides for oncology

sophomer_ctverec.jpg

Sophomer

Syntetic polymer for immunoassays

dracen_edited.jpg

Dracen Pharmaceuticals

Tumor-Directed Glutamine Antagonist

periotrap_edited.jpg

PerioTrap

Curative treatment of periodontitis

sulfotools_edited.jpg

Sulfotools

Green peptide synthesis technology

lamx_edited.jpg

LAM-X

Light-activated nanomaterials fighting infections

sampling human_mensi4.jpg

Sampling Human

Yeast cell based biocomputing

logo DMCH barva vyska ctverec_edited.jpg

Deep MedChem

AI-based tools accelerating drug discovery

Our exits

diana_edited.jpg

DIANA Biotechnologies

Pharmaceuticals and highly sensitive diagnostic methods

elphogene_edited.jpg

Elphogene

Liquid biopsy technology for cancer diagnostics

riocath_edited.jpg

Riocath

New technology used in the production of catheters.

bottom of page